Piramal Enterprises | PEL | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Cash and cash equiva... |
| 15,409 | 24,670 | 8,107 | 47,711 | 70,247 |
Short-term investment |
| 34,640 | 51,985 | 24,982 | 29,504 | 35,621 |
Accounts receivables |
| 11,077 | 13,555 | 14,063 | 13,244 | 15,447 |
Inventories |
| 7,231 | 7,740 | 8,351 | 10,612 | 12,992 |
Deferred income taxes |
| 0 | 0 | 0 | 0 | 0 |
Other current assets |
| 19,233 | 20,204 | 67,240 | 60,060 | 64,367 |
Total current assets |
| 87,590 | 118,154 | 122,742 | 161,131 | 198,674 |
Gross property plant... |
| 14,651 | 21,450 | 26,565 | 24,329 | 27,329 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 14,651 | 21,450 | 26,565 | 24,329 | 27,329 |
Work in Progress |
| 7,324 | 2,941 | 0 | 2,661 | 4,008 |
Miscellaneous Investment |
| 275,518 | 448,134 | 0 | 483,464 | 476,720 |
Deferred income taxes |
| 6,252 | 42,444 | 40,685 | 23,723 | 9,372 |
Intangible assets |
| 32,277 | 33,010 | 30,945 | 29,128 | 27,570 |
Goodwill |
| 54,272 | 56,326 | 59,395 | 11,391 | 11,143 |
Other long-term assets |
| 4,510 | 4,375 | 575,930 | 13,258 | 16,372 |
Total non-current assets |
| 394,804 | 608,680 | 733,519 | 587,955 | 572,514 |
Total assets |
| 482,394 | 726,834 | 856,261 | 749,086 | 771,189 |
Short-term debt |
| 120,795 | 146,659 | 290,036 | 79,499 | 33,625 |
Accounts Payable... |
| 7,643 | 8,743 | 9,573 | 9,898 | 11,784 |
Provisions |
| 1,135 | 934 | 0 | 2,444 | 1,659 |
Taxes Payable |
| 375 | 571 | 1,368 | 2,129 | 1,897 |
Deferred Revenues |
| 0 | 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 28 | 395 | 475 |
Other current liabilities |
| 55,631 | 60,379 | 9,805 | 142,365 | 84,033 |
Total current liabilities |
| 185,578 | 217,285 | 310,810 | 236,730 | 133,473 |
Long-term debt |
| 144,957 | 242,206 | 270,196 | 203,063 | 280,968 |
Investments Liabilities |
| 0 | 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 308 | 292 | 195 | 82 | 2,227 |
Provisions |
| 736 | 421 | 0 | 652 | 302 |
Capital Leases |
| 0 | 0 | 24 | 1,442 | 1,404 |
Other longterm liabilities |
| 1,857 | 2,056 | 2,415 | 1,401 | 1,427 |
Total non-current liabilities |
| 147,857 | 244,975 | 272,830 | 206,640 | 286,327 |
Total liabilities |
| 333,436 | 462,260 | 583,640 | 443,370 | 419,799 |
Share Capital |
| 345 | 361 | 369 | 451 | 451 |
Share premium |
| 0 | 0 | 30,037 | 0 | 0 |
Retained earnings |
| 148,481 | 264,093 | 114,054 | 305,265 | 339,729 |
Accumulated other equity |
| 0 | 0 | 128,070 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 | 0 |
Minority Interest |
| 132 | 120 | 90 | 0 | 11,210 |
Total Equity |
| 148,958 | 264,574 | 272,621 | 305,716 | 351,390 |
Total Liabilities and Equity |
| 482,394 | 726,834 | 856,261 | 749,086 | 771,189 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |